These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19188446)

  • 41. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway.
    Ives A; Le Roy D; Théroude C; Bernhagen J; Roger T; Calandra T
    FASEB J; 2021 May; 35(5):e21418. PubMed ID: 33774873
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress.
    Koga K; Kenessey A; Powell SR; Sison CP; Miller EJ; Ojamaa K
    Antioxid Redox Signal; 2011 Apr; 14(7):1191-202. PubMed ID: 20831446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity suppresses microglia-mediated inflammatory responses.
    Zhang Y; Gu R; Jia J; Hou T; Zheng LT; Zhen X
    Clin Exp Pharmacol Physiol; 2016 Nov; 43(11):1134-1144. PubMed ID: 27543936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MIF signal transduction initiated by binding to CD74.
    Leng L; Metz CN; Fang Y; Xu J; Donnelly S; Baugh J; Delohery T; Chen Y; Mitchell RA; Bucala R
    J Exp Med; 2003 Jun; 197(11):1467-76. PubMed ID: 12782713
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
    Wang C; Zhou X; Li W; Li M; Tu T; Ba X; Wu Y; Huang Z; Fan G; Zhou G; Wu S; Zhao J; Zhang J; Chen J
    Cancer Lett; 2017 Sep; 403():271-279. PubMed ID: 28642171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
    Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
    J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.
    Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y
    J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
    Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
    Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studying the Pro-Migratory Effects of MIF.
    Hoffmann A; Zwißler LC; El Bounkari O; Bernhagen J
    Methods Mol Biol; 2020; 2080():1-18. PubMed ID: 31745866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.
    O'Reilly C; Doroudian M; Mawhinney L; Donnelly SC
    Med Res Rev; 2016 May; 36(3):440-60. PubMed ID: 26777977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of chromenes as inhibitors of macrophage migration inhibitory factor.
    Kok T; Wapenaar H; Wang K; Neochoritis CG; Zarganes-Tzitzikas T; Proietti G; Eleftheriadis N; Kurpiewska K; Kalinowska-Tłuścik J; Cool RH; Poelarends GJ; Dömling A; Dekker FJ
    Bioorg Med Chem; 2018 Mar; 26(5):999-1005. PubMed ID: 29428527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MIF-chemokine receptor interactions in atherogenesis are dependent on an N-loop-based 2-site binding mechanism.
    Kraemer S; Lue H; Zernecke A; Kapurniotu A; Andreetto E; Frank R; Lennartz B; Weber C; Bernhagen J
    FASEB J; 2011 Mar; 25(3):894-906. PubMed ID: 21106938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: a potential biomarker for anti-inflammatory intervention.
    Healy ZR; Liu H; Holtzclaw WD; Talalay P
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1516-23. PubMed ID: 21602309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
    Xia W; Zhang F; Xie C; Jiang M; Hou M
    Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma.
    D'Amato-Brito C; Cipriano D; Colin DJ; Germain S; Seimbille Y; Robert JH; Triponez F; Serre-Beinier V
    Oncotarget; 2016 Mar; 7(10):11512-25. PubMed ID: 26883190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of MIF family proteins: MIF and DDT from rock bream, Oplegnathus fasciatus.
    Oh M; Kasthuri SR; Wan Q; Bathige SD; Whang I; Lim BS; Jung HB; Oh MJ; Jung SJ; Kim SY; Lee J
    Fish Shellfish Immunol; 2013 Aug; 35(2):458-68. PubMed ID: 23688964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model.
    Tilstam PV; Schulte W; Holowka T; Kim BS; Nouws J; Sauler M; Piecychna M; Pantouris G; Lolis E; Leng L; Bernhagen J; Fingerle-Rowson G; Bucala R
    J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34850744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection.
    Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM
    Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evolving complexity of MIF signaling.
    Jankauskas SS; Wong DWL; Bucala R; Djudjaj S; Boor P
    Cell Signal; 2019 May; 57():76-88. PubMed ID: 30682543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti-Proliferative Activity in Lung Cancer Cells.
    Xiao Z; Song S; Chen D; van Merkerk R; van der Wouden PE; Cool RH; Quax WJ; Poelarends GJ; Melgert BN; Dekker FJ
    Angew Chem Int Ed Engl; 2021 Aug; 60(32):17514-17521. PubMed ID: 34018657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.